Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs231430 | chr17:3265138 | T/C | 0.000226 | 171 | 18.1 | 25.43 | 27.2 | KM Plot |
PCPG | rs231431 | chr17:3265905 | C/T | 0.000226 | 171 | 18.1 | 25.43 | 27.2 | KM Plot |
PCPG | rs2315351 | chr3:182474041 | A/G | 1.19E-5 | 174 | 13.27 | 25.85 | 25.53 | KM Plot |
PCPG | rs2317343 | chr6:123123683 | G/A | 1.46E-8 | 173 | 7.03 | 26.53 | 24.85 | KM Plot |
PCPG | rs2323165 | chr13:37569200 | A/G | 0.00031 | 176 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs2323393 | chr13:37657072 | C/A | 0.000286 | 176 | 26.27 | 24.23 | 4.17 | KM Plot |
PCPG | rs2327147 | chr6:131710397 | A/G | 5.05E-7 | 178 | 15.33 | 27.78 | 24.85 | KM Plot |
PCPG | rs2329552 | chr22:21263551 | C/T | 2.42E-5 | 176 | 12.93 | 31.9 | 25.4 | KM Plot |
PCPG | rs2358627 | chr14:74631489 | A/G | 2.29E-5 | 175 | 25.4 | 26.92 | 10.43 | KM Plot |
PCPG | rs2369488 | chr16:1734655 | T/C | 1.43E-11 | 175 | 25.47 | 19.3 | 4.52 | KM Plot |
PCPG | rs2371454 | chr12:56647243 | A/G | 9.68E-8 | 178 | 0.8 | 29.13 | 25.17 | KM Plot |
PCPG | rs2372447 | chr3:80546259 | T/C | 6.02E-5 | 178 | 19.87 | 24.03 | 27.2 | KM Plot |
PCPG | rs2372448 | chr3:80546383 | T/C | 6.02E-5 | 178 | 19.87 | 24.03 | 27.2 | KM Plot |
PCPG | rs2372654 | chr3:80598175 | T/C | 0.00013 | 176 | 19.87 | 24.53 | 27.4 | KM Plot |
PCPG | rs2372655 | chr3:80598114 | A/G | 7.96E-5 | 174 | 19.53 | 24.03 | 27.4 | KM Plot |